Page 2,276«..1020..2,2752,2762,2772,278..2,2902,300..»

TYSABRI and MS – My Journey #53 and wondering about stem cells… – Video

Posted: August 31, 2013 at 11:40 pm


TYSABRI and MS - My Journey #53 and wondering about stem cells...
I #39;ve had Tysabri 53 and I #39;m feeling good. I #39;m very interested in Stem Cell research though. Obviously I can #39;t spell either since I typed "cellls" instead of ...

By: Sandra Watts

Follow this link:
TYSABRI and MS - My Journey #53 and wondering about stem cells... - Video

Posted in Stem Cell Videos | Comments Off on TYSABRI and MS – My Journey #53 and wondering about stem cells… – Video

Human Brains Grown In Test-Tubes! – Video

Posted: August 31, 2013 at 11:40 pm


Human Brains Grown In Test-Tubes!
GET OUR AWESOME NEW POSTER! http://bit.ly/13GPNM4 Scientists in Vienna have created a tiny human brain using stem cells. Our Sources: http://lat.ms/1550sgl M...

By: SourceFed

Read the original here:
Human Brains Grown In Test-Tubes! - Video

Posted in Stem Cell Videos | Comments Off on Human Brains Grown In Test-Tubes! – Video

Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India – Video

Posted: August 31, 2013 at 5:44 pm


Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India
Improvement seen in just 6 months after Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Earli...

By: Neurogen Brain and Spine Institute

Read the rest here:
Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India - Video

Posted in Stem Cell Therapy | Comments Off on Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India – Video

Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma – Video

Posted: August 31, 2013 at 5:44 pm


Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma
Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma. He is a known case of MD with history of gradual onset of progressive lower extremities...

By: Neurogen Brain and Spine Institute

View post:
Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma - Video

Posted in Stem Cell Therapy | Comments Off on Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma – Video

Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy – Video

Posted: August 31, 2013 at 5:44 pm


Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy...

By: Neurogen Brain and Spine Institute

Original post:
Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy - Video

Posted in Stem Cell Therapy | Comments Off on Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy – Video

Four UCLA stem cell researchers receive CIRM Early Translational grants

Posted: August 30, 2013 at 4:07 pm

Four researchers from UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational Research Awards totaling approximately $13 million from the California Institute for Regenerative Medicine, the state's stem cell agency. The UCLA researchers received four of the 12 total awards; no other institution received more than one.
 
The Independent Citizens Oversight Committee, CIRM’s governing body, announced at its Aug. 28 meeting in La Jolla, Calif., that grant recipients included Dr. Jerome Zack, professor of medicine and microbiology, immunology and molecular genetics; Dr. Robert Reiter, Bing Professor of Urologic Research; Dr. Donald Kohn, professor of pediatrics and microbiology, immunology and molecular genetics in th...

MedWorm Sponsor Message: Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

Source:
http://www.medworm.com/index.php?rid=7551755&cid=c_449_44_f&fid=38766&url=http%3A%2F%2Fnewsroom.ucla.edu%2Fportal%2Fucla%2Ffour-prominent-ucla-stem-cell-248077.aspx%3Flink_page_rss%3D248077

Posted in Gene therapy | Comments Off on Four UCLA stem cell researchers receive CIRM Early Translational grants

Tracking the Fruits of California Stem Cell Agency Research

Posted: August 30, 2013 at 11:44 am

The California stem
cell agency yesterday shed some interesting light on the awards in its $41
million round this week and their pathway to actually producing a product that
can be used to treat persons who are suffering from diseases.

It is a difficult and
long journey to generate usable therapies, a process poorly understood by the
public, which was promised in 2004 that the stem cell agency would produce
cures for ailments afflicting half the population of the state.

Writing on the agency’s blog, Amy Adams, CIRM communications manager, dealt with the issue indirectly.
She said,

“Many scientists who
receive our early translation awards first got their idea for a therapy while
carrying out research with one of our other awards. In fact, eight of the
scientists in this round of funding had previous CIRM funding for an earlier
stage of research. If a scientist's early translation award provides good
results, the scientists are then able to apply for one of our disease team
awards, which fund the effort of compiling data to convince the Food and Drug
Administration to allow them to test it in people.  Other organizations
fund only early discovery research or only preclinical research. Under those
conditions, researchers continually pause their projects to look for new
sources of funding as the project moves through the phases toward clinical
trial.”

One of the virtues of
the California stem cell agency is its promise of a continued stream of
funding. Former Chairman Robert Klein used to tout that particular aspect of
the agency, particularly in light of limited federal resources.

Adams’ comments
implicitly raise important questions concerning CIRM’s entire portfolio. How
many CIRM grants have led to additional funding from CIRM? How many are
basically one-off shots that have not led to research that has advanced the
development of stem cell therapies, either via CIRM or other funding. What is the
therapeutic and scientific significance of the research that is linked by more
than one CIRM award?  What previously
funded CIRM research could be fruitfully funded again to advance the science
and not necessarily through the traditional grant rounds, which sometimes have
awkward timing?

Unmentioned in Adams’
item is an application from a UC Irvine researcher that came up at Wednesday’s
meeting of the governing board of the stem cell agency. The woman, whose name
was not clearly audible on the Internet audiocast, publicly appealed rejection
of her application by reviewers. She noted that it was an extension of work
that was previously funded by the agency. She also noted that the score on her
review was all but identical to work that was funded. The board, however,
turned her appeal aside, which had already been rejected behind closed doors by
CIRM staff.

Hers is not the only
such case in CIRM history. But they are virtually impossible to track systematically
because of the structure of the CIRM grant-making progress. It is also not
clear whether the agency itself is tracking its research awards to determine if
they result in continuing, fruitful research in a specific area. Nonetheless,
the matter deserves some public attention. 

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/iPivfY1LHPk/tracking-fruits-of-california-stem-cell.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on Tracking the Fruits of California Stem Cell Agency Research

UCLA Takes Four of 13 Awards Today; One Business Wins

Posted: August 28, 2013 at 8:17 pm

The California stem cell agency has
made it official, sending out its press release on the $41 million in grants
approved today for institutions throughout the state. 

Most of the 13 awards, as usual, went to organizations represented on the governing board of
the agency. Individual board members, however, are barred from voting on specific grants
to their organizations. 
UCLA topped the list with four grants. No other
institution received more than one, including only one business, Numerate, Inc., of San Bruno,
via John
Griffin, the firm's chief scientific officer. The lack of awards
to businesses has long been a sore subject in the biotech community.  
The only news story so far was written by Bradley Fikes of the San Diego U-T, which circulates in an area that is a hotbed of biotech research. Institutions there snagged $12.6 million in four grants. Fikes also
identified one of the five researchers who lost their appeals on negative grant
review decisions. He is Evan
Snyder, leader of stem cell research at Sanford-Burnham Medical Research
Institute in La Jolla, who
had a $5 million request before the agency.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/cdlc-HWVO2c/ucla-takes-four-of-13-awards-today-one.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on UCLA Takes Four of 13 Awards Today; One Business Wins

Stem Cell Agency Seeks Stronger Ties with Possible Industry Funding Partners

Posted: August 28, 2013 at 6:50 pm

The California stem cell agency today triggered a new program aimed at recruiting major biotech and venture capital firms to assist in providing tens of millions of dollars for research by California enterprises.

The effort, part of an $80 million business-friendly initiative, was approved by the agency's governing board on a voice vote.

Participating companies will have a special relationship with the state agency, according to a staff document. The "industry collaborators" will have early input into concept funding proposals prior to their presentation to the agency's governing board. The companies will also be able to attend agency workshops and meetings involving hundreds of grant recipients. 
Other aspects of the proposal call for special event-hosting arrangements aimed at creating more collaborations along with posting of information from the selected collaborators on the CIRM website.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/TEKA-IbpQCo/stem-cell-agency-seeks-stronger-ties.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on Stem Cell Agency Seeks Stronger Ties with Possible Industry Funding Partners

UCLA Snags $3.6 Million from California Stem Cell Agency

Posted: August 28, 2013 at 4:34 pm

UCLA scored today with at least two grants, totaling $3.6 million, from the California stem cell agency. 

Seeking the cash were Donald Kohn,  application 6823, and Gerald Lipshutz, application 6831. Both of the  grants are for $1.8 million each. 


Their applications were initially in the agency's tier two category, which means that CIRM's reviewers did not approve them outright for funding.  CIRM staff, however, did under a new procedure, and the agency's governing ratified the recommendation. 

Lipshutz also appeared before the board along with several patient advocates who made emotional appeals for funding. Lipshutz's research deals with urea cycle disorders, which occur in one out of 8,200 births. Current treatment is arduous and can involve liver transplants.  

Kohn's research deals with sickle cell disease, which afflicts primarily African-Americans. His efforts are aimed at correcting the sickle gene defect in the blood stem cells before transplanting them back into the patient.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/2AMVhKsdgfc/ucla-snags-36-million-from-california.html

Posted in Stem Cells, Stem Cell Therapy | Comments Off on UCLA Snags $3.6 Million from California Stem Cell Agency

Page 2,276«..1020..2,2752,2762,2772,278..2,2902,300..»